Literature DB >> 15198949

Severe hemochromatosis in a Portuguese family associated with a new mutation in the 5'-UTR of the HAMP gene.

Thomas Matthes1, Patricia Aguilar-Martinez, Loredana Pizzi-Bosman, Régis Darbellay, Laura Rubbia-Brandt, Emilio Giostra, Martine Michel, Tomas Ganz, Photis Beris.   

Abstract

Juvenile hereditary hemochromatosis is a genetically heterogeneous disorder transmitted as an autosomal recessive trait. It is most often caused by mutations in the HJV gene and rarely in the HAMP gene. Hepcidin is considered to constitute a negative regulator of iron absorption, and its production is increased in inflammatory states and iron overload. We report the detection of a new mutation in the HAMP gene leading to juvenile hemochromatosis in 2 members of a Portuguese family. The mutation lies in the 5'-UTR (untranslated region) of the gene and creates a new initiation codon in the context of a Kozak sequence. We found no trace of hepcidin protein in the patients' urine, suggesting that ribosomes select the mutant initiation codon for translation. The decrease of hepcidin production would thus lead to increased iron absorption, resulting in iron deposition in parenchymal tissues. Phlebotomy therapy of the 2 patients resulted in impressive clinical improvement.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15198949     DOI: 10.1182/blood-2004-01-0332

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

Review 1.  Non-HFE hemochromatosis: genetics, pathogenesis, and clinical management.

Authors:  James E Nelson; Kris V Kowdley
Journal:  Curr Gastroenterol Rep       Date:  2005-02

Review 2.  Hemojuvelin: a supposed role in iron metabolism one year after its discovery.

Authors:  Peter Celec
Journal:  J Mol Med (Berl)       Date:  2005-05-05       Impact factor: 4.599

3.  A new mutation in the hepcidin promoter impairs its BMP response and contributes to a severe phenotype in HFE related hemochromatosis.

Authors:  Marie-Laure Island; Anne-Marie Jouanolle; Annick Mosser; Yves Deugnier; Véronique David; Pierre Brissot; Olivier Loréal
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

Review 4.  Non-HFE haemochromatosis.

Authors:  Daniel-F Wallace; V-Nathan Subramaniam
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

5.  Upstream open reading frames cause widespread reduction of protein expression and are polymorphic among humans.

Authors:  Sarah E Calvo; David J Pagliarini; Vamsi K Mootha
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-16       Impact factor: 11.205

Review 6.  Hepcidin modulation in human diseases: from research to clinic.

Authors:  Alberto Piperno; Raffaella Mariani; Paola Trombini; Domenico Girelli
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

Review 7.  Ethnic Differences in Iron Status.

Authors:  Wanhui Kang; Alexa Barad; Andrew G Clark; Yiqin Wang; Xu Lin; Zhenglong Gu; Kimberly O O'Brien
Journal:  Adv Nutr       Date:  2021-10-01       Impact factor: 8.701

8.  5'UTR mutations of ENG cause hereditary hemorrhagic telangiectasia.

Authors:  Kristy Damjanovich; Carmen Langa; Francisco J Blanco; Jamie McDonald; Luisa M Botella; Carmelo Bernabeu; Whitney Wooderchak-Donahue; David A Stevenson; Pinar Bayrak-Toydemir
Journal:  Orphanet J Rare Dis       Date:  2011-12-22       Impact factor: 4.123

9.  HFE genotyping in patients with elevated serum iron indices and liver diseases.

Authors:  Andreia Silva Evangelista; Maria Cristina Nakhle; Thiago Ferreira de Araújo; Clarice Pires Abrantes-Lemos; Marta Mitiko Deguti; Flair José Carrilho; Eduardo Luiz Rachid Cançado
Journal:  Biomed Res Int       Date:  2015-01-14       Impact factor: 3.411

10.  Evolution of the hepcidin gene in primates.

Authors:  Ludovica Segat; Alessandra Pontillo; Michele Milanese; Alessandro Tossi; Sergio Crovella
Journal:  BMC Genomics       Date:  2008-03-05       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.